Sr-One-Capital-Management-Lp

AI_NATIVE detailed information: This accession holds the following tickers:[
  "MLYS",
  "ALMS",
  "KALA",
  null,
  "NKTX",
  "ZBIO",
  "SPRY",
  "ACLX",
  null,
  "DSGN",
  "ORKA",
  "CRSP"
]

Filing Details

13F-HR • 2025-03-31

SEC FilingSEC DataHachi Filing

Report Date: 2025-03-31
Filing Date: 2025-05-13
Total Holdings: 12
Total Value: 389283283
Accession Number: 0000950123-25-004926
Form Type: 13F-HR
CIK: sr-one-capital-management-lp
Manager Name: Sr-One-Capital-Management-Lp

Data Enrichment

83% identified

10 identified2 unidentified

Holdings

SEC FilingSEC DataHachi Filing

Manager:

12 positions • $389.3M total value

SEC FilingSEC DataHachi Filing

Manager:

Search and click to pin securities to the top

Sort by:

Arcellx, Inc.

ACLX|03940C100

Shares:2.3M

Value:$153.9M

% of Portfolio:39.5% ($153.9M/$389.3M)

ARS Pharmaceuticals, Inc.

SPRY|82835W108

Shares:4.0M

Value:$50.5M

% of Portfolio:13.0% ($50.5M/$389.3M)

Mineralys Therapeutics, Inc.

MLYS|603170101

Shares:3.1M

Value:$49.7M

% of Portfolio:12.8% ($49.7M/$389.3M)

Zenas BioPharma, Inc.

ZBIO|98937L105

Shares:4.9M

Value:$38.8M

% of Portfolio:10.0% ($38.8M/$389.3M)

CRISPR Therapeutics AG

CRSP|H17182108

Shares:1.0M

Value:$35.7M

% of Portfolio:9.2% ($35.7M/$389.3M)

Design Therapeutics, Inc.

DSGN|25056L103

Shares:6.5M

Value:$25.2M

% of Portfolio:6.5% ($25.2M/$389.3M)

ALUMIS INC.

ALMS|022307102

Shares:2.0M

Value:$12.0M

% of Portfolio:3.1% ($12.0M/$389.3M)

H5870P102

Shares:322.5K

Value:$6.1M

% of Portfolio:1.6% ($6.1M/$389.3M)

Nkarta, Inc.

NKTX|65487U108

Shares:3.3M

Value:$6.1M

% of Portfolio:1.6% ($6.1M/$389.3M)

Oruka Therapeutics, Inc.

ORKA|687604108

Shares:430.3K

Value:$4.4M

% of Portfolio:1.1% ($4.4M/$389.3M)

KALA BIO, Inc.

KALA|483119202

Shares:598.9K

Value:$3.4M

% of Portfolio:0.9% ($3.4M/$389.3M)

29286M105

Shares:747.8K

Value:$3.3M

% of Portfolio:0.9% ($3.3M/$389.3M)

Instrument	Shares		Other Manager	Value	% of Portfolio
Arcellx, Inc.(ACLXcusip03940C100)	2.3M	QoQ 0.00% (-0) YoY 0.00% (-0)	All Managers (Combined)	$153.9M	39.5% ($153.9M/$389.3M)	QoQ -14.46% (-$26.0M) YoY -5.67% (-$9.3M)
ARS Pharmaceuticals, Inc.(SPRYcusip82835W108)	4.0M	QoQ 0.00% (+0) YoY 0.00% (+0)	All Managers (Combined)	$50.5M	13.0% ($50.5M/$389.3M)	QoQ +19.24% (+$8.1M) YoY +23.09% (+$9.5M)
Mineralys Therapeutics, Inc.(MLYScusip603170101)	3.1M	QoQ +55.09% (+1.1M) YoY +55.09% (+1.1M)	All Managers (Combined)	$49.7M	12.8% ($49.7M/$389.3M)	QoQ +100.07% (+$24.8M) YoY +90.77% (+$23.6M)
Zenas BioPharma, Inc.(ZBIOcusip98937L105)	4.9M	QoQ 0.00% (-0) YoY NEW(+4.9M)	All Managers (Combined)	$38.8M	10.0% ($38.8M/$389.3M)	QoQ -3.54% (-$1.4M) YoY NEW(+$38.8M)
CRISPR Therapeutics AG(CRSPcusipH17182108)	1.0M	QoQ 0.00% (-0) YoY 0.00% (-0)	All Managers (Combined)	$35.7M	9.2% ($35.7M/$389.3M)	QoQ -13.54% (-$5.6M) YoY -50.07% (-$35.8M)
Design Therapeutics, Inc.(DSGNcusip25056L103)	6.5M	QoQ 0.00% (-0) YoY 0.00% (-0)	All Managers (Combined)	$25.2M	6.5% ($25.2M/$389.3M)	QoQ -37.43% (-$15.1M) YoY -4.21% (-$1.1M)
ALUMIS INC.(ALMScusip022307102)	2.0M	QoQ 0.00% (-0) YoY NEW(+2.0M)	All Managers (Combined)	$12.0M	3.1% ($12.0M/$389.3M)	QoQ -21.88% (-$3.4M) YoY NEW(+$12.0M)
(cusipH5870P102)✕	322.5K	QoQ NEW(+322.5K) YoY NEW(+322.5K)	All Managers (Combined)	$6.1M	1.6% ($6.1M/$389.3M)	QoQ NEW(+$6.1M) YoY NEW(+$6.1M)
Nkarta, Inc.(NKTXcusip65487U108)	3.3M	QoQ 0.00% (-0) YoY 0.00% (-0)	All Managers (Combined)	$6.1M	1.6% ($6.1M/$389.3M)	QoQ -26.10% (-$2.2M) YoY -82.97% (-$29.9M)
Oruka Therapeutics, Inc.(ORKAcusip687604108)	430.3K	QoQ 0.00% (-0) YoY NEW(+430.3K)	All Managers (Combined)	$4.4M	1.1% ($4.4M/$389.3M)	QoQ -47.08% (-$3.9M) YoY NEW(+$4.4M)
KALA BIO, Inc.(KALAcusip483119202)	598.9K	QoQ 0.00% (-0) YoY NEW(+598.9K)	All Managers (Combined)	$3.4M	0.9% ($3.4M/$389.3M)	QoQ -17.43% (-$724.7K) YoY NEW(+$3.4M)
(cusip29286M105)✕	747.8K	QoQ 0.00% (-0) YoY NEW(+747.8K)	All Managers (Combined)	$3.3M	0.9% ($3.3M/$389.3M)	QoQ -32.63% (-$1.6M) YoY NEW(+$3.3M)